Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.01 USD | -1.85% | -0.11% | +17.19% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 504M |
---|---|---|---|---|---|
Net income 2024 * | -90M | Net income 2025 * | -111M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.25
x | P/E ratio 2025 * |
-5.22
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Astria Therapeutics, Inc.
1 day | +2.68% | ||
1 week | +2.34% | ||
Current month | -3.06% | ||
1 month | -3.87% | ||
3 months | -33.72% | ||
6 months | +85.45% | ||
Current year | +19.53% |
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 08-06-25 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 11-03-31 |
Chief Tech/Sci/R&D Officer | 54 | 22-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 13-12-31 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 19-01-03 |
Director/Board Member | 75 | 16-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.00% | 34 M€ | +4.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 9.018 | -1.76% | 34 610 |
24-06-05 | 9.18 | +2.74% | 442,286 |
24-06-04 | 8.935 | -2.46% | 431,984 |
24-06-03 | 9.16 | -3.27% | 752,786 |
24-05-31 | 9.47 | +5.11% | 821,409 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.53% | 504M | |
+18.72% | 125B | |
+14.53% | 109B | |
-2.88% | 24.74B | |
+4.89% | 22.67B | |
-9.74% | 18.14B | |
-41.04% | 16.67B | |
-11.83% | 16.64B | |
+1.46% | 13.45B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- ATXS Stock